Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03358524Phase 4Completed
Phase 4, randomised, double-blind trial (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Isoprostane at 8 weeks. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03358524.